| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 04/28/2004 | EP1412491A2 Compositions and methods utilizing dna polymerases |
| 04/28/2004 | EP1412489A2 Fatty acid desaturase gene obtained from pomegranate and method for the production of unsaturated fatty acids |
| 04/28/2004 | EP1412488A1 Method for producing arachidonic acid in transgenic organisms |
| 04/28/2004 | EP1412485A1 Antigen presenting cells, method for their preparation and their use for cancer vaccines |
| 04/28/2004 | EP1412482A2 Uses of opg ligand to modulate immune responses |
| 04/28/2004 | EP1412481A2 Mesenchymal cells and osteoblasts from human embryonic stem cell |
| 04/28/2004 | EP1412479A2 Cells of the cardiomyocyte lineage produced from human pluripotent stem cells |
| 04/28/2004 | EP1412477A2 GPCs AS MODIFIERS OF THE IRRTK AND P21 PATHWAYS AND METHODS OF USE |
| 04/28/2004 | EP1412387A2 Transporters and ion channels |
| 04/28/2004 | EP1412386A2 USE OF PEPTIDE FRAGMENTS OF THE CALCIUM CHANNEL $g(A)-1 SUBUNIT, OPTIONALLY COMPRISING MUTATIONS, FOR SCREENING MOLECULES OF THERAPEUTIC INTEREST |
| 04/28/2004 | EP1412385A2 Modified insulin with reduced immunogenicity |
| 04/28/2004 | EP1412382A2 Interferon gamma polypeptide variants |
| 04/28/2004 | EP1412381A2 Meningococcus adhesins nada, app and orf40 |
| 04/28/2004 | EP1412379A2 Antigenic polypeptides |
| 04/28/2004 | EP1412378A1 Aptamers and antiaptamers |
| 04/28/2004 | EP1412377A1 Production of high molecular mass lectins |
| 04/28/2004 | EP1412375A2 Alteration of oil traits in plants |
| 04/28/2004 | EP1412374A2 Novel pgc-1 isoforms and uses therefor |
| 04/28/2004 | EP1412373A2 Alteration of oil traits in plants |
| 04/28/2004 | EP1412372A2 Endogenous and non-endogenous versions of human g protein-coupled receptors |
| 04/28/2004 | EP1412371A1 IN VIVO PRODUCTION OF SMALL INTERFERING RNAs THAT MEDIATE GENE SILENCING |
| 04/28/2004 | EP1411983A1 Bispecific antibodies that bind to vegf receptors |
| 04/28/2004 | EP1411980A2 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 04/28/2004 | EP1411979A1 Vaccine comprising gp120 and nef and/or tat for the immunisation against hiv |
| 04/28/2004 | EP1411975A1 Methylation of histone h4 at arginine 3 |
| 04/28/2004 | EP1411974A2 Materials and methods relating to improved vaccination strategies |
| 04/28/2004 | EP1411971A1 Use of long pentraxin ptx3 for treating female infertility |
| 04/28/2004 | EP1411970A2 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 04/28/2004 | EP1411969A1 Modified protamine with reduced immunogenicity |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411963A2 Cytotoxic factors for modulating cell death |
| 04/28/2004 | EP1411962A2 Monoclonal antibody therapy for pancreas cancer |
| 04/28/2004 | EP1411897A2 Compositions and methods for intracellular delivery |
| 04/28/2004 | EP1411880A2 Recombinant vsv for the treatment of tumor cells |
| 04/28/2004 | EP1411770A2 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 04/28/2004 | EP1411769A2 Efficient methods for assessing and validating candidate protein-based therapeutic molecules encoded by nucleic acid sequences of interest |
| 04/28/2004 | EP1411762A2 Combinations of genes for producing seed plants exhibiting modulated reproductive development |
| 04/28/2004 | EP1411761A2 Metabolite transporters |
| 04/28/2004 | EP1382688A9 Screening method |
| 04/28/2004 | EP1326628B1 Chemokine mutants in the treatment of multiple sclerosis |
| 04/28/2004 | EP1307539A4 Gene expression profile for kshv infection and methods for treating same |
| 04/28/2004 | EP1272846A4 Compositions and methods for induction of proteins involved in xenobiotic metabolism |
| 04/28/2004 | EP1198489B1 Combinations for introducing nucleic acids into cells |
| 04/28/2004 | EP1144656B1 Method for the isolation of ccc plasmid dna |
| 04/28/2004 | EP1129215B1 Ligation assembly and detection of polynucleotides on solid-support |
| 04/28/2004 | EP1128841B1 Pharmaceutical preparation containing a receptor-antagonist for treating blood-clotting disorders |
| 04/28/2004 | EP1104231A4 Biodegradable high oxidative stability oils |
| 04/28/2004 | EP1084232B1 Genetically-modified fibroblasts and the use thereof |
| 04/28/2004 | EP1062318B1 A prokaryotic cell comprising two copies of a gene transcribed in different directions |
| 04/28/2004 | EP1012190A4 Eosinophil eotaxin receptor |
| 04/28/2004 | EP0944723B1 Mammalian chemokines |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0910642B1 A method for increasing hemoprotein production in filamentous fungi |
| 04/28/2004 | EP0885309B1 Direct molecular diagnosis of friedreich ataxia |
| 04/28/2004 | EP0856054B1 Monoclonal antibody br110 and uses thereof |
| 04/28/2004 | EP0840741B1 Pna-dna chimeras and pna synthons for their preparation |
| 04/28/2004 | EP0799317B1 Method for secreting thrombopoietin polypeptides |
| 04/28/2004 | EP0787201B1 Poly(organo)phosphazenes for use in synthetic transfection systems |
| 04/28/2004 | EP0784682B1 Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/28/2004 | EP0777498B1 Conjugates made of metal complexes and oligonucleotides |
| 04/28/2004 | EP0730469B1 Modified truncated complement system regulators |
| 04/28/2004 | EP0698095B1 Bmp-10 compositions |
| 04/28/2004 | EP0694063B1 An alpha-amylase from pyrococcus |
| 04/28/2004 | EP0626861B2 Treatment for asthma |
| 04/28/2004 | EP0555315B1 HUMAN CELL LINE STABLY EXPRESSING 5cDNAs ENCODING PROCARCINOGEN-ACTIVATING ENZYMES |
| 04/28/2004 | CN1493052A Method for identification of T-cell epitopes and use for preparing molecules with reduced immunogenicity |
| 04/28/2004 | CN1492931A Process for producing prenyl alcohol |
| 04/28/2004 | CN1492930A Anti-interferon-šŒantibodies |
| 04/28/2004 | CN1492929A Myocyte differentiation factor Fwa 267 |
| 04/28/2004 | CN1492928A Cell proliferation factor Fwap 10576 |
| 04/28/2004 | CN1492927A Human FGF23 protein mutant lowering blood phosphorus level |
| 04/28/2004 | CN1492926A Preferred segments of neural thread protein and methods of using the same |
| 04/28/2004 | CN1492925A Rice sucrose transporter gene promoter |
| 04/28/2004 | CN1492924A Genes encoding proteolytic enzymes from aspargilli |
| 04/28/2004 | CN1492923A 减毒的活疫苗 Attenuated live vaccine |
| 04/28/2004 | CN1492879A Protein tau |
| 04/28/2004 | CN1492875A TTK in diagnosis and as a therapeutic target in cancer |
| 04/28/2004 | CN1492768A Artificial proteins with reduced immunogenicity |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492756A Amphoteric liposomes and the use thereof |
| 04/28/2004 | CN1492050A Method for raising fibroblast growth factor expression quantity Pichia yeast secretes and expresses |
| 04/28/2004 | CN1492049A Process for producing L-leucine |
| 04/28/2004 | CN1492048A Novel nitrile hydratase |
| 04/28/2004 | CN1492047A Recmobined plasmid containing c-fos promotor and reporter gene and its producing method and use |
| 04/28/2004 | CN1492046A Genetic sequence of coded flavonoid path enzyme and its use |
| 04/28/2004 | CN1492043A Novel nitrile hydratase |
| 04/28/2004 | CN1492042A Novel nitrile hydratase |
| 04/28/2004 | CN1492040A Natural antibody of monoclonal human |
| 04/28/2004 | CN1491962A Myb transcription factor of cotton and its encoding gene and use |
| 04/28/2004 | CN1491960A Rice DREB transcription factor and its encoding gene and use |
| 04/28/2004 | CN1491956A Gene for changing cotton fiber quantity and character and its encoding protein and use |
| 04/28/2004 | CN1491624A Modified biological material |
| 04/28/2004 | CN1147588C Process for preparing peptide antibiotics with efficient expression |
| 04/28/2004 | CN1147587C Method of strengthening specific destination gene expression of cell |
| 04/28/2004 | CN1147586C Nucleotide sequences of HIV-10 type (or subtype) retrovirus antigens |
| 04/28/2004 | CN1147585C Two-component signal system gene and the protein encoded by it |
| 04/28/2004 | CN1147584C Modulators of tissue regeneration |
| 04/28/2004 | CN1147583C Molecular mark of soybean salt-tolerance gene and its acquiring method and application |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/27/2004 | US6727412 For resistance to diseases, insects, heat, drought; better crop maturity, yield, agronomic quality, uniformity, germination, stand establishment, growth rate, plant & ear height |